Archived Media

The goal of pharmaceutical development is to deliver novel therapies that can significantly improve the lives...

Highly specialized drug products and capacity needs drive increased reliance on contract service providers.

Highly specialized drug products and capacity needs drive increased reliance on contract service providers.

Collaboration will ensure GMP production of material for Phase I clinical trial of Scancell’s DNA vaccine against SARS-CoV-2.

To add large-scale lyophilization and sterile fill-finish capabilities to its clinical and commercial manufacturing offering.

To add large-scale lyophilization and sterile fill-finish capabilities to its clinical and commercial manufacturing offering.

Closes investment from Oak HC/FT to accelerate growth; Jenn Adams named chief executive officer.

Cell and gene therapies represent the new wave of innovation in the life sciences industry